Skip to content

Clinical trials

Phase 3 Leukemia trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 3 Country / region: Czechia Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20073
20102
20111
20123
20144
20151
20161
20172
20191
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status8
Active, not recruiting4
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC8
Novartis Pharmaceuticals4
Daiichi Sankyo3
AbbVie1
Acerta Pharma BV1
Amgen1
Antisoma Research1
Ariad Pharmaceuticals1
Celgene1
Dutch Childhood Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia32
Leukemia, Myeloid, Acute11
Leukemia, Lymphocytic, Chronic, B-Cell6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Leukemia, Myeloid5
Bone Marrow Diseases4
Myelodysplastic Syndromes4
Hematologic Diseases3
Hematologic Neoplasms3
Myeloproliferative Disorders3

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.